Agilysys, Inc. (AGYS) Cash Flow Statement
Agilysys, Inc. (AGYS) generated $82.2M of operating cash flow over the twelve months to 2026-06-30, spent $1.7M on capital expenditure and had free cash flow of $80.4M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AGYSAgilysys, Inc.Follow AGYS — free
—
Price chart with a free account
- Market cap
- 3.4B
- P/E TTM
- 79.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 26 Oct, in 2 days
| Line | FY2012 Mar 12 | FY2013 Mar 13 | FY2014 Mar 14 | FY2015 Mar 15 | FY2016 Mar 16 | FY2017 Mar 17 | FY2018 Mar 18 | FY2019 Mar 19 | FY2020 Mar 20 | FY2021 Mar 21 | FY2022 Mar 22 | FY2023 Mar 23 | FY2024 Mar 24 | FY2025 Mar 25 | FY2026 Mar 26 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -21.7 | -10.7 | 0.1 | -2.2 | 7.2 | 3.4 | 6.9 | 7.2 | 10.6 | 28.4 | 28.5 | 34.5 | 48.2 | 55.1 | 70.0 | 82.2 | |
| Capital expenditure | 2.2 | 2.5 | 4.0 | 4.7 | 5.9 | 4.2 | 6.1 | 3.3 | 3.4 | 1.4 | 1.2 | 7.2 | 8.1 | 2.8 | 1.8 | -1.7 | |
| Free cash flow | -23.9 | -13.2 | -4.0 | -6.8 | 1.3 | -0.7 | 0.7 | 3.9 | 7.2 | 27.0 | 27.3 | 27.2 | 40.1 | 52.3 | 68.1 | 80.4 | |
| Share repurchases | 13.2 | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Stock-based compensation | 2.4 | 1.6 | 2.1 | 3.1 | 3.4 | 2.4 | 4.7 | 4.4 | 5.2 | 40.1 | 14.5 | 13.0 | 14.1 | 17.8 | 21.8 | — |
USD millions · SEC XBRL
Agilysys, Inc. — questions
- What is Agilysys, Inc.'s operating cash flow?
- $82.2M over the twelve months to 2026-06-30.
- How much does Agilysys, Inc. spend on capital expenditure?
- $1.7M over the twelve months to 2026-06-30.
- What is Agilysys, Inc.'s free cash flow?
- $80.4M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Agilysys, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.